Navigation Links
GlaxoSmithKline and Shire Enter Agreement to Co-Promote Vyvanse(R) (lisdexamfetamine dimesylate) CII for Adult Attention Deficit Hyperactivity Disorder
Date:3/30/2009

RESEARCH TRIANGLE PARK, N.C., March 31 /PRNewswire-FirstCall/ -- GlaxoSmithKline plc (NYSE: GSK) has entered into a co-promotion agreement with Shire plc (LSE: SHP, Nasdaq: SHPGY) for Vyvanse(R), to help improve the recognition and treatment of adult Attention Deficit Hyperactivity Disorder (ADHD). This 3-year agreement covers the United States only and will add an important product to the GSK Neurosciences portfolio.

"GSK has been active in discovering and developing medicines to treat psychiatric disorders for decades, and neuroscience is one of the company's key therapeutic categories," said Deirdre Connelly, President, GlaxoSmithKline North American Pharmaceuticals. "Our professional

sales representatives are well positioned to provide physicians with information on the treatment of adult ADHD with Vyvanse and we look forward to helping meet the needs of adult patients with ADHD."

"Shire believes GSK is our ideal partner to promote Vyvanse because of its strength and leadership in CNS treatments," said Michael Cola, President of Shire's Specialty Pharmaceuticals business. "By collaborating with GSK, we are better positioned to reach psychiatrists and primary care physicians with treatment information about adult ADHD."

The GSK sales force is expected to begin promoting Vyvanse to physicians in May 2009.

Vyvanse is a prodrug of dextroamphetamine, a stimulant, which is therapeutically inactive until metabolized in the body. Vyvanse is currently available in six dosage strengths o
'/>"/>

SOURCE GlaxoSmithKline plc
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6

Related medicine news :

1. GlaxoSmithKline Responds to JAMA Articles
2. MedImmune Licenses Reverse Genetics Technology to GlaxoSmithKline for Use in Influenza Vaccine Development and Production
3. Congressional Black Caucus Foundation and GlaxoSmithKline Announce Supplier Business Initiative Study Results
4. AUDIO from Medialink and GlaxoSmithKline: A New Nasal Spray for Allergy Relief
5. Mylan Announces Settlement of Paroxetine Hydrochloride Extended-Release Tablets with GlaxoSmithKline
6. GlaxoSmithKline Aids California Fire Relief Efforts
7. Genmab and GlaxoSmithKline Initiate Ofatumumab Rheumatoid Arthritis Phase III Program
8. GlaxoSmithKline Obtains Exclusive U.S. OTC Marketing Rights to MEVACOR(R) (lovastatin) from Merck & Co., Inc.
9. Pharmacopeia and GlaxoSmithKline Collaboration Identifies Two Additional Lead Compounds
10. GlaxoSmithKline Presents Innovative Neuroscience Pipeline
11. GlaxoSmithKline Receives FDA Complete Response Letter for Cervical Cancer Vaccine
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/19/2013)... The muscles in the human body ... one of the biggest and most significant nervous systems ... peripheral system comprises of peripheral nerves that reside outside ... ensure that the limbs and hands, as well as ... get damaged due to trauma or physical injury, their ...
(Date:5/19/2013)... 2013 Grinding your teeth at night ... or annoying your spouse. At the same time, according ... (“Snoring and Teeth Grinding Could Be a Sign of ... can be hard to prevent. Apparently, Obstructive Sleep Disorder ... of its symptoms is a habit of teeth grinding ...
(Date:5/19/2013)... TX (PRWEB) May 19, 2013 6Webs.com ... systems companies. Homeowners who are considering an alarm ... services of the nation's leading security system providers online ... reviews the best DIY home security system ... year 6Webs.com reviews dozens of home security companies before ...
(Date:5/19/2013)... The report “Feed Additives Market by Types, Livestock ... 2017” published by MarketsandMarkets, defines and segments the global ... the global volume and revenue for the animal feed ... for the global market with analysis of trends, opportunities, ... segmented and revenue is forecasted on the basis of ...
(Date:5/19/2013)... 2013 The Pradaxa lawyers at Bernstein ... recently convened for hundreds of Pradaxa bleeding ... in U.S. District Court, Southern District of Illinois. ... May 14th, the Conference addressed the status of depositions ... the Conference that Defendants submitted a list of early ...
Breaking Medicine News(10 mins):Health News:Ultimate Neuropathy Support System Launched by Neuracel - Reaching New Heights in Herbal Medication for Peripheral Neuropathy 2Health News:Dr. Kanani, Woodland Hills Dentist: Dangers of Tooth Damage and Obstructive Sleep Disorder 2Health News:Dr. Kanani, Woodland Hills Dentist: Dangers of Tooth Damage and Obstructive Sleep Disorder 3Health News:Top Rated DIY Home Security System Companies Published by 6Webs.com 2Health News:Feed Additives Market to Reach $19.5 Billion by 2017 at a CAGR of 3.8% - New Report by MarketandMarkets 2Health News:Feed Additives Market to Reach $19.5 Billion by 2017 at a CAGR of 3.8% - New Report by MarketandMarkets 3Health News:Pradaxa Lawyers at Bernstein Liebhard LLP Report on Recent Status Conference in Federal Pradaxa Litigation 2Health News:Pradaxa Lawyers at Bernstein Liebhard LLP Report on Recent Status Conference in Federal Pradaxa Litigation 3
... Order Halting July 1st Wage Cut , , OAKLAND, ... Thursday evening upon hearing the news that a U.S. District Court ... a proposed $2 an hour cut in wages for the state,s ... pay cuts in all California counties that were planning on passing ...
... for former GM and Delphi workers in restructuring , ... Ohio congressional members and U.S. Sen. Sherrod Brown (D-OH) to ... today, urging ,simple justice, with equity in financial support for ... represented by the United Steelworkers (USW) and two other unions. ...
... Rayner, executive director of the New Jersey Lawsuit Reform ... organizations dedicated to improving the state,s civil justice system ... in the courts, today issued the following statement in ... discontinue Accutane(R), a treatment for severe acne: , ...
... red meat and dairy products, study finds, , FRIDAY, ... and dairy products can increase your risk for pancreatic ... , Pancreatic cancer, which is usually fatal, is the ... Various risk factors for developing the disease have been ...
... Corporation, the company that will become public from the planned ... announced that Robert Friel will serve on the company,s board ... , Friel, 53, is chairman and chief executive officer of ... and safety of people and the environment. He joined PerkinElmer ...
... firing led to doctor,s claims of slander, breach of contract , ... an $8.6 million judgment against his employer two years ago won ... favor. , , The Court of Appeals for ... favor of Dr. Neal Fisher following a 2007 judgment against Pinnacle ...
Cached Medicine News:Health News:Judge Rules on SEIU Lawsuit 2Health News:Ohio Congressional Members Urge U.S. to Provide GM Retirees Medical Benefits 2Health News:Ohio Congressional Members Urge U.S. to Provide GM Retirees Medical Benefits 3Health News:Eating Animal Fat May Lead to Pancreatic Cancer 2Health News:Eating Animal Fat May Lead to Pancreatic Cancer 3Health News:CareFusion Names Robert Friel to Board of Directors 2Health News:CareFusion Names Robert Friel to Board of Directors 3Health News:Appeals Court OKs Multimillion-Dollar Judgment for Dallas Doctor 2
(Date:5/18/2013)... NEW YORK , May 18, 2013 /PRNewswire/ ... securities law firm, is investigating potential securities fraud ... (NASDAQ: AVEO). (Logo: http://photos.prnewswire.com/prnh/20120119/MM38856LOGO ... the Company and its executives violated federal securities ... regarding the Company,s Phase III drug trials for ...
(Date:5/17/2013)... 2013 Medical devices are any medical items ... In light of their different mechanisms, actions and regulatory ... complicated than drug trails due to their unique clinical ... of evaluating both safety and efficacy (which is left ... the same as the SFDA) evaluate MDs for both ...
(Date:5/17/2013)...  Sorrento Therapeutics, Inc. (OTCBB: SRNE; or STI) ... Business Technology Transfer Research (STTR) grant (#1R42AI098182-02) from ... (NIAID), a division of the National Institutes of ... antibody therapeutics to combat Staphylococcus aureus ... methicillin-resistant S. aureus (MRSA), was renewed ...
Breaking Medicine Technology:Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses In Excess Of $100,000 Investing In AVEO Pharmaceuticals, Inc. To Contact The Firm 2Statistical Challenges in Medical Device Trail Evaluation 2Sorrento Therapeutics, Inc. announces its approach to developing human antibody therapeutics against MRSA receives continued support from the National Institute of Allergy and Infectious Diseases 2Sorrento Therapeutics, Inc. announces its approach to developing human antibody therapeutics against MRSA receives continued support from the National Institute of Allergy and Infectious Diseases 3Sorrento Therapeutics, Inc. announces its approach to developing human antibody therapeutics against MRSA receives continued support from the National Institute of Allergy and Infectious Diseases 4
... indicates that anti-inflammatory drugs may become a new tool ... leading global cause of death. In investigating a specific ... researchers used the Cardiochip, a gene analysis tool designed ... Center for Applied Genomics at The Children,s Hospital of ...
... March 14, 2012 OncoSec Medical Incorporated ... Medical System (OMS) ElectroOncology therapies to treat solid ... Institute in Santa Monica, CA, and Lakeland Comprehensive ... as enrolling sites, and investigators are screening patients ...
Cached Medicine Technology:Gene Chip, Invented by Children's Hospital of Philadelphia Scientist, Pinpoints New Target to Prevent Heart Disease 2Gene Chip, Invented by Children's Hospital of Philadelphia Scientist, Pinpoints New Target to Prevent Heart Disease 3OncoSec Initiates Two Additional Clinical Sites for Phase II Metastatic Melanoma Trial 2OncoSec Initiates Two Additional Clinical Sites for Phase II Metastatic Melanoma Trial 3OncoSec Initiates Two Additional Clinical Sites for Phase II Metastatic Melanoma Trial 4
... is ideal as a primary chemistry-immuno ... and laboratories or as a dedicated ... and consolidate chemistry-immuno testing with Olympus ... chemistry, specific proteins, esoteric chemistries and ...
This kit has been designed for the quantitative,determination of total immunoreactive intact PTH (Total,Intact PTH) in blood samples. The Total Intact PTH,level is the sum of PTH (1-84) and N-t...
... PoleStar N20, exclusively distributed by Medtronic, ... Combining intra-operative imaging with surgical ... PoleStar N20 is one of the ... , , Exceptional image quality from ...
Microwell IRMA for the detection of Intact PTH...
Medicine Products: